Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kaletra”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04499677
What this trial is testing

FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals

Who this might be right for
COVID-19
University College, London 240
Post-approval studies (Phase 4)Study completedNCT00268827
What this trial is testing

A Comparison Study of Kaletra Soft-Gel Capsules and Kaletra Tablets in an African American Cohort

Who this might be right for
HIV-1AIDS
AIDS Arms Inc. 120
Post-approval studies (Phase 4)Ended earlyNCT00100984
What this trial is testing

A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1

Who this might be right for
HIV Infection
Hoffmann-La Roche 8
Large-scale testing (Phase 3)Study completedNCT02845843
What this trial is testing

MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b

Who this might be right for
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
King Abdullah International Medical Research Center 95
Post-approval studies (Phase 4)Study completedNCT00114933
What this trial is testing

"OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects

Who this might be right for
HIV Infection
Arribas, Jose R., M.D. 200
Post-approval studies (Phase 4)Study completedNCT00192621
What this trial is testing

Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects

Who this might be right for
HIV InfectionsDyslipidemiasGlucose Metabolism Disorders+3 more
Kirby Institute 50
Post-approval studies (Phase 4)Study completedNCT01818258
What this trial is testing

IMPAACT P1092: Steady State PK in Malnourished HIV Infected Children

Who this might be right for
HIV PositiveMalnourished
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 52
Early research (Phase 1)Ended earlyNCT00743470
What this trial is testing

A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects

Who this might be right for
HIVTuberculosis
Abbott 15
Large-scale testing (Phase 3)Study completedNCT00035932
What this trial is testing

Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV

Who this might be right for
HIV Infections
Bristol-Myers Squibb 571
Post-approval studies (Phase 4)UnknownNCT01049685
What this trial is testing

Lopinavir/Ritonavir or Efavirenz as First-line Antiretroviral Therapy

Who this might be right for
HIV Infections
UPECLIN HC FM Botucatu Unesp 36
Large-scale testing (Phase 3)UnknownNCT00437476
What this trial is testing

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy

Who this might be right for
HIV InfectionsHepatitis C
IRCCS San Raffaele 60
Testing effectiveness (Phase 2)Study completedNCT00400738
What this trial is testing

The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected Patients

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 48
Not applicableStudy completedNCT01328158
What this trial is testing

Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infection

Who this might be right for
Human Immunodeficiency Virus Infection
AbbVie (prior sponsor, Abbott) 236
Not applicableStudy completedNCT01097655
What this trial is testing

Study on the Usage, Dosing, Tolerability, and Effectiveness of Kaletra Tablet

Who this might be right for
Human Immunodeficiency Virus
AbbVie (prior sponsor, Abbott) 3,049
Post-approval studies (Phase 4)Study completedNCT00700115
What this trial is testing

Kaletra-isentress Treatment Evaluation

Who this might be right for
HIV Infections
Emory University 60
Post-approval studies (Phase 4)Ended earlyNCT00420355
What this trial is testing

Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients

Who this might be right for
HIV Infection
University of Oklahoma 19
Post-approval studies (Phase 4)UnknownNCT04779047
What this trial is testing

Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients.

Who this might be right for
Covid19Pneumonia
October 6 University 150
Testing effectiveness (Phase 2)Study completedNCT00084149
What this trial is testing

Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 54
Testing effectiveness (Phase 2)Study completedNCT00270296
What this trial is testing

Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 730
Post-approval studies (Phase 4)Study completedNCT00385645
What this trial is testing

Atazanavir or Lopinavir in HIV Post-exposure Prophylaxis

Who this might be right for
HIV Infections
Hospital Clinic of Barcelona 255
Next Page